RET fusion mutation detected by re-biopsy 7 years after initial cytotoxic chemotherapy: A case report

Personalized medicine using molecular-targeted drugs to achieve better therapeutic response and long-term prognosis is common practice for lung cancer treatment. However, in cases before gene batch tests were available, medical treatment continued without the detection of rare mutations. We report a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Kei Morikawa, Hiroshi Handa, Junko Ueno, Hajime Tsuruoka, Takeo Inoue, Naoki Shimada, Junki Koike, Seiji Nakamura, Yoshiharu Sato, Masamichi Mineshita
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-11-01
coleção:	Frontiers in Oncology
Assuntos:	RET mutation detected by re-biopsy case report gene mutation re-biopsy RET fusion lung cancer selpercatinib
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1019932/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!